Free Articles, Free Web Content, Reprint Articles
Tuesday, January 25, 2022
 
Free Articles, Free Web Content, Reprint ArticlesRegisterAll CategoriesTop AuthorsSubmit Article (Article Submission)ContactSubscribe Free Articles, Free Web Content, Reprint Articles
 

The diabetes drug delivery devices market is estimated to be worth USD 31 billion in 2030, predicts

Owing to over a decade of extensive R&D, the novel diabetes drug delivery devices, such as insulin pumps and pen-injectors, offer a safe and convenient solution to diabetic patients who are required to medicate on a frequent basis

Roots Analysis is pleased to announce the publication of its recent study, titled, “Diabetes Drug Delivery Devices Market, 2020-2030

 

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these devices over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of device developers engaged in the development of diabetes drug delivery devices.
  • A detailed competitive analysis of diabetes drug delivery devices based on supplier power and product specifications.
  • An analysis of the partnerships that have been inked by the stakeholders in this domain, in the recent past.
  • Detailed profiles of developers of diabetes drug delivery devices (shortlisted on the basis of the number of devices developed).
  • An analysis of recent initiatives undertaken by big pharma players engaged in this domain.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Pen-Injectors
  • Insulin Pumps
  • Conventional Syringes
  • Others 
  • Route of Administration
  • Subcutaneous
  • Intravenous
  • Others
  • Type of Diabetes
  • Type 1
  • Type 2
  • Usability of the Device
  • Disposable
  • Reusable
  • Key Geographies 
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 
  • Type of Device

 

Key companies covered in the report 

  • Bigfoot Biomedical
  • Debiotech
  • Haselmeier
  • Medtronic
  • Novo Nordisk
  • Roche
  • SOOIL
  • Ypsomed

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/diabetes-drug-delivery-devices-market.html or email sales@rootsanalysis.com

 

Other Recent Offerings

  1. Organ–based / Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030
  2. Global Handheld Ultrasound Imaging Devices Market, 2020-2030
  3. Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices
  4. Medical Device CROs Market (2nd Edition), 2020 – 2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needsFree Reprint Articles, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

Source: Free Articles from ArticlesFactory.com

ABOUT THE AUTHOR


Owing to over a decade of extensive R&D, the novel diabetes drug delivery devices, such as insulin pumps and pen-injectors, offer a safe and convenient solution to diabetic patients who are required to medicate on a frequent basis



Health
Business
Finance
Travel
Technology
Home Repair
Computers
Marketing
Autos
Education
Entertainment
Family
Law
Other
Communication
ECommerce
Sports
Home Business
Internet
Self Help
Partners


Page loaded in 0.180 seconds